Transgenic zebrafish for modeling hepatocellular carcinoma

Area of Science:

• Oncology and Genetics
• Comparative Medicine

Background:

• Liver cancer is a major global health burden, causing over 0.6 million deaths annually.
• Identifying novel therapeutic targets and understanding oncogenic mechanisms require effective in vivo models.
• Genetically modified zebrafish (Danio rerio) are emerging as valuable models for cancer research due to organ similarity and rapid genetic manipulation.

Purpose of the Study:

• To review epidemiological data and genetic alterations in hepatocellular carcinoma (HCC).
• To summarize the utility and application of zebrafish models in HCC research.
• To discuss potential therapeutic strategies for HCC informed by zebrafish studies.

Main Methods:

• Review of existing literature on liver cancer epidemiology, genetics, and zebrafish cancer models.
• Analysis of genetic alterations and oncogene candidates identified through high-throughput genomic technologies.
• Evaluation of spontaneous tumor development and therapeutic responses in genetically modified zebrafish.

Main Results:

• Zebrafish models exhibit organ structures and genetic pathways relevant to human HCC.
• These models allow for rapid, cost-effective in vivo testing of oncogenic mechanisms and drug responses.
• Insights from zebrafish studies are guiding the development of novel therapeutic strategies for liver cancer.

Conclusions:

• Zebrafish represent a powerful preclinical model for advancing liver cancer research.
• Understanding genetic alterations in HCC, coupled with insights from zebrafish models, is crucial for developing effective treatments.
• Further research using zebrafish holds promise for identifying new pharmacological targets and therapeutic interventions for hepatocellular carcinoma.